Mental health care continues to evolve as researchers investigate new ways to support people experiencing depression and trauma-related conditions. Among the treatments receiving scientific attention is TMS therapy, also known as Transcranial Magnetic Stimulation. While TMS is an established treatment option for certain people with depression, researchers are also investigating its potential role in post-traumatic stress disorder (PTSD).

For Australians exploring mental health treatment options, understanding the differences between established treatments and emerging research is essential. This guide explains how TMS works, what current evidence suggests about TMS PTSD and depression, and what patients should discuss with a qualified mental health professional.

Understanding PTSD and Depression in Australia

Post-traumatic stress disorder can develop after experiencing or witnessing a traumatic event. Symptoms may include intrusive memories, nightmares, avoidance of reminders, heightened alertness, sleep difficulties, and changes in mood.

TMS Depression can involve persistent sadness, reduced interest in daily activities, fatigue, concentration difficulties, and feelings of hopelessness. PTSD and depression can occur together, making assessment and treatment planning particularly important.

An Australian study published in 2026 examined national mental health survey data collected between 2020 and 2022. It reported a lifetime PTSD prevalence of 7.1% in the study sample, highlighting the importance of accessible, evidence-based mental health support. The study also identified associations between PTSD and other mental and physical health conditions.

These findings reinforce the need for appropriate assessment and individualised treatment rather than relying on a single approach for every patient.

What Is TMS Therapy?

TMS therapy is a non-invasive procedure that uses magnetic pulses to stimulate specific regions of the brain. It is delivered through a specialised device positioned near the scalp.

The treatment is designed to influence neural activity in brain circuits associated with mood regulation. For TMS depression clinicians commonly target the dorsolateral prefrontal cortex, although the precise protocol depends on the clinical indication.

Unlike treatments that require surgery or general anaesthesia, routine TMS sessions are generally performed while the patient remains awake. Patients attend scheduled appointments and can usually return to their usual activities afterwards, subject to medical advice.

TMS is most established for certain cases of major depressive disorder, particularly when previous treatments have not provided adequate improvement. Its potential applications for other psychiatric conditions are an active area of research.

TMS for PTSD: What Does the Latest Research Show?

Researchers are investigating whether repetitive Transcranial Magnetic Stimulation (rTMS) can help reduce PTSD symptoms by influencing brain networks involved in fear, emotional regulation, and responses to stressful memories.

A systematic review and meta-analysis published in August 2026 examined the efficacy and safety of rTMS for PTSD. The review found a significant reduction in self-reported PTSD symptoms compared with sham stimulation. However, the difference was not statistically significant for symptoms assessed through clinical interviews.

The researchers also noted that evidence about sustained benefits after treatment was limited and uncertain. Findings concerning co-occurring anxiety and depression were heterogeneous.

These results suggest that rTMS may have potential for PTSD, but further high-quality research is needed to establish which patients may benefit, which protocols are most appropriate, and how long any improvement may last.

Importantly, TMS should not be presented as a guaranteed treatment or a universal replacement for established PTSD therapies. Patients interested in this approach should discuss the available evidence and appropriate options with a qualified clinician.

How Can Transcranial Magnetic Stimulation Help With Depression?

Transcranial Magnetic Stimulation has a more established clinical role in treating certain forms of depression than it does in treating PTSD.

Depression can involve changes in the activity and communication of neural networks associated with mood and motivation. TMS delivers repeated magnetic pulses to targeted areas of the brain to influence these circuits.

For appropriately selected patients, treatment may help reduce depressive symptoms. Some people experience improvements in mood, concentration, motivation, or daily functioning, although responses vary.

TMS may be considered when antidepressant medication or psychotherapy has not produced sufficient improvement. It may also be used alongside other treatments when clinically appropriate.

A psychiatrist determines suitability by reviewing the patient's diagnosis, previous treatments, medical history, and individual circumstances.

TMS Therapy for PTSD vs Depression

Although PTSD and depression can share symptoms, they are different conditions and require appropriate clinical assessment.

This comparison highlights why treatment decisions should be based on the specific condition being treated rather than assuming that evidence for depression automatically applies to PTSD.

What Happens During a TMS Treatment Session?

Patients considering TMS therapy generally begin with a clinical assessment. The treating professional reviews symptoms, previous treatments, medical history, and any factors that may affect safety.

If TMS is considered appropriate, the clinical team identifies the treatment target and establishes the required settings. During a session, a magnetic coil is positioned near the scalp and delivers controlled pulses.

Patients may experience tapping sensations or temporary scalp discomfort. Sessions are repeated according to the prescribed protocol, and progress is monitored throughout treatment.

The duration and frequency of appointments depend on the treatment protocol and clinical indication. Patients should ask their provider about the expected schedule, potential side effects, costs, and follow-up arrangements before beginning treatment.

Is TMS Therapy Safe?

TMS is generally well tolerated when patients are appropriately screened and treatment is delivered by trained professionals. Common side effects include headache, scalp tenderness, or discomfort around the stimulation site.

Seizures are a rare but serious potential complication. Certain implanted devices, metal implants near the treatment area, and other medical circumstances may require additional assessment or make treatment unsuitable.

Patients should provide their clinician with relevant information about medical conditions, medications, and implanted devices.

For PTSD specifically, the evidence base is still developing. The potential benefits, risks, and uncertainties should be considered carefully, and TMS should not replace an established treatment plan without professional guidance.

What Other Treatments Are Available for PTSD?

Evidence-based psychological treatments remain central to PTSD care. Depending on the individual's needs, a clinician may recommend trauma-focused cognitive behavioural therapy, cognitive processing therapy, prolonged exposure therapy, or eye movement desensitisation and reprocessing (EMDR).

Medication may also be considered in selected circumstances. Treatment decisions depend on symptom severity, personal preferences, previous responses, and other clinical factors.

TMS may be discussed in a research or specialist context where appropriate, but patients should not assume it is an established or routinely funded treatment for PTSD in Australia.

Accessing TMS Therapy in Australia

Australians interested in TMS can begin by discussing their symptoms and treatment history with a GP or psychiatrist. A qualified specialist can explain whether TMS is suitable, what alternatives are available, and whether the patient meets relevant eligibility requirements.

Medicare-funded rTMS is subject to specific criteria and should not be assumed to cover every diagnosis. Funding arrangements for depression do not automatically extend to PTSD.

TMS HUBB provides information about rTMS services in Queensland, including its clinics in Brisbane CBD, Stones Corner, and Loganholme. Patients can contact the team to discuss available services, assessment pathways, and eligibility.

Frequently Asked Questions

Is TMS therapy approved for PTSD in Australia?

TMS has an established role in certain depression treatment pathways, but its use for PTSD remains an evolving area of research. Patients should confirm the clinical status, availability, and funding of any proposed treatment with a qualified specialist.

Can TMS treat both PTSD and depression?

Research is investigating TMS for PTSD, and it is an established option for certain patients with depression. When both conditions occur together, a psychiatrist must determine an appropriate treatment plan for each condition.

How many TMS sessions are needed?

The number of sessions depends on the clinical indication and prescribed protocol. A treating professional can explain the expected schedule following an assessment.

Can TMS replace trauma-focused therapy?

TMS should not automatically replace evidence-based psychological treatment for PTSD. Patients should discuss the benefits and limitations of each option with their treating professional.

Conclusion

TMS therapy is an established treatment option for certain people with depression, while its potential role in PTSD continues to be studied. Recent research suggests that rTMS may reduce some PTSD symptoms, but findings are mixed and longer-term benefits remain uncertain.

Understanding the distinction between established treatment and emerging evidence can help Australians make informed decisions about mental health care. Patients should seek professional guidance to explore suitable options based on their individual needs.

Visit TMS HUBB to learn more about rTMS services in Queensland and discuss available assessment pathways with the clinical team.